Diversified Trust CO Immuno Gen, Inc. Transaction History

Diversified Trust CO

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 08, 2024	SELL	$12.46 - $29.95 $113,672 - $273,233	-9,123 Reduced 21.46%	33,394 $990,000
Q3 2023 Nov 17, 2023	BUY	$14.09 - $19.87 $25,333 - $35,726	1,798 Added 4.42%	42,517 $674,000
Q2 2023 Jul 18, 2023	BUY	$3.75 - $20.05 $6,052 - $32,360	1,614 Added 4.13%	40,719 $768,000
Q3 2022 Oct 14, 2022	SELL	$4.48 - $6.47 $9,282 - $13,405	-2,072 Reduced 5.03%	39,105 $187,000
Q4 2021 Jan 13, 2022	BUY	$4.75 - $7.5 $17,180 - $27,127	3,617 Added 9.63%	41,177 $306,000
Q2 2021 Jul 20, 2021	BUY	$5.79 - $8.6 $10,126 - $15,041	1,749 Added 4.88%	37,560 $248,000
Q1 2021 May 10, 2021	SELL	$6.5 - $10.53 $36,094 - $58,473	-5,553 Reduced 13.42%	35,811 $290,000
Q4 2020 Jan 08, 2021	BUY	$3.7 - $7.66 $29,422 - $60,912	7,952 Added 23.8%	41,364 $267,000
Q2 2020 Jul 07, 2020	BUY	$3.32 - $5.34 $110,927 - $178,420	33,412 New	33,412 $154,000

1.41M

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

Get notified when there are updates to the investment portfolio of Diversified Trust CO, based on Form 13F filings with the SEC.

Stay updated on Diversified Trust CO with notifications on news.